The table below shows Co-Diagnostics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$7.85M
-$8.75M
-$8.49M
-$5.92M
$7.81M
$12.27M
Capital expenditure
$142.02K
$91.91K
$402.29K
$179.94K
$396.60K
$139.56K
Investing cash flow
-$142.02K
$7.36M
$16.67M
-$10.21M
$858.67K
$2.39M
Dividends paid
-
-
-
-
CODX operating cash flow (10-K history)
Co-Diagnostics, Inc. reported operating cash flow of -$29.14M for fiscal year 2025. That is up 0.1% from -$29.16M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$1.31M (FY 2016) to -$29.14M. Figures come from the company's audited annual reports as filed with the SEC.